Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 600-606

  Smith, Nicola A ^a,e   Sabin, Caroline A ^b   Gopal, Robin ^c   Bourboulia, Dimitra ^d   Labbet, Wendy ^c   Boshoff, Chris ^d   Barlow, David ^a   Band, Barbara ^a   Peters, Barry S ^a   De Ruiter, Annemiek ^a   Brown, David W G ^c   Weiss, Robin A ^d   Best, Jennifer M ^a,g   Whitby, Denise ^d,f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e CHARING CROSS HOSPITAL   (United Kingdom)

^f NATIONAL CANCER INSTITUTE   (United States)

^g ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICA; AGED; ARTICLE; FEMALE; HERPES SIMPLEX VIRUS 2; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; VIRUS TRANSMISSION;

EID: 0032880127     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314926     Document Type: Article

References (24)

1. 1. Boshoff C, Weiss RA. Kaposi's sarcoma-associated herpesvirus, Adv Cancer Res 1998;75:57-86.
2. 2. Ganem D, KSHV and Kaposi's sarcoma: the end of the beginning, Cell 1997;91:157-60.
3. 3. Moore PS, Chang Y. Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol 1998;147:217-21.
4. 4. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2: 925-8.
5. 5. Kedes DH. Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-24.
6. 6. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61.
7. 7. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;348: 1133-8.
8. 8. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. HHV-8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998;90:395-7.
9. 9. Calabro ML, Sheldon J, Favero A, et al. Seroprevalence of Kaposi's sarcoma associated herpesvirus/human herpesvirus 8 in several regions in Italy, J Hum Virol 1998;1:207-13.
10. 10. Sitas F, Carrara H, Beral V, et al. Association between HHV-8, HIV, cancer and selected risk factors in South Africa [abstract 1]. Presented at the 2d National AIDS Malignancy Conference, Bethesda, Maryland, 1988.
11. 11. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335: 123-8.
12. 12. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998;338:948-54.
13. 13. Bourboulia D, Whitby D, Boshoff C, et al. Serological evidence for vertical transmission of KSHV/HHV-8 in healthy South African children. JAMA 1998;280:31-2.
14. 14. Barlow D, Daker-White G, Band B. Assortative sexual mixing in a heterosexual clinic population a limiting factor in HIV spread? AIDS 1997; 11:1039-44.
15. 15. Boshoff C, Gao SJ, Healy LE, et al. Establishment of a KSHV positive cell line (BCP-1) from peripheral blood and characterizing its growth in vivo. Blood 1998;91:1671-9.
16. 16. Slomka MJ, Ashley RL, Cowan FM, Cross A, Brown DWG. Monoclonal antibody blocking tests for the detection of HSV-1 and HSV-2 -specific humoral responses: comparison with Western blot assay. J Virol Methods 1995;55:27-35.
17. 17. SAS Institute. SAS/STAT user's guide, version 6. 4th ed. Cary, NC. SAS Institute, 1992.
18. 18. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as Serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9.
19. 19. Miller G, Rigsby MO, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma associated herpesvirus in patients with HIV-1 infection, N Engl J Med 1996;334:1292-7.
20. 20. Chatlynne LG, Lapps W, Handy M, et al. Detection and titration of human herpesvirus-8-specific antibodies on sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998;92: 1-6.
21. 21. Luppi M, Whitby D, Barozzi P, et al. Age and sex specific prevalence of human herpesvirus 8. J Natl Cancer Inst 1998;90:1103-4.
22. 22. Rabkin CS, Schulz TF, Whitby D, et al. Interassay correlation of HHV-8 serologic tests. J Infect Dis 1998;178:304-9.
23. 23. de The G, Geser A, Day NE, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978;274:756-61.
24. 24. de The G, Lavoue MF, Muenz L. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. IARC Sci Publ 1978;20:471-81.